Pavel N. Pichurin

Dr. Pavel N. Pichurin is a Medical Geneticist at Mayo Clinic Children's in Rochester, Minnesota, specializing in Pediatric Hematology/Oncology within the Clinical Genomics Specialty Groups. He holds board certification in Clinical Genetics and Genomics from the American Board of Medical Genetics and Genomics and maintains active membership in numerous professional organizations including the American College of Medical Genetics and Genomics, Society for Inherited Metabolic Disorders, and National Comprehensive Cancer Network.

Dr. Pichurin's research interests focus on Von Hippel-Lindau syndrome, inborn errors of metabolism, cancer genetics, and general genetics. His clinical work includes management of genetic disorders, hereditary hemorrhagic telangiectasia, metabolic disorders, and performing skin biopsies. His research spans neurodevelopmental disorders, lysosomal storage diseases, and genomic medicine implementation.

Analysis of Dr. Pichurin's publication record reveals a strong focus on clinical genomics, with recent work examining rare genetic variants, diagnostic approaches to genetic conditions, and implementation of genomic medicine in clinical practice. His research often involves international collaborations and focuses on translating genomic findings into clinical applications.

• 2018 Top Doctor by Minnesota Monthly
• 1990 State Award of Recognition of Excellent Achievements in Histology
• 1990 State Award of Recognition of Excellent Achievements in Human Anatomy

Dr. Pichurin actively contributes to genomic medicine through his involvement in the Mayo Clinic Tapestry Study and other initiatives focused on improving diagnostic yield through exome sequencing. His work bridges clinical practice and research, with a particular emphasis on complex genetic conditions affecting pediatric patients. He serves as Lead Physician Patient education liaison for the department of Clinical Genomics and participates in the Colorectal eTumor Board.

Dr. Pichurin's laboratory and team work focuses on clinical genomics and translational research, with particular attention to improving diagnostic approaches for rare genetic conditions and implementing genomic medicine in clinical practice.